516 related articles for article (PubMed ID: 16435058)
1. Ursodeoxycholic acid therapy for intractable total parenteral nutrition-associated cholestasis in surgical very low birth weight infants.
Al-Hathlol K; Al-Madani A; Al-Saif S; Abulaimoun B; Al-Tawil K; El-Demerdash A
Singapore Med J; 2006 Feb; 47(2):147-51. PubMed ID: 16435058
[TBL] [Abstract][Full Text] [Related]
2. Ursodeoxycholic acid (UDCA) therapy in very-low-birth-weight infants with parenteral nutrition-associated cholestasis.
Chen CY; Tsao PN; Chen HL; Chou HC; Hsieh WS; Chang MH
J Pediatr; 2004 Sep; 145(3):317-21. PubMed ID: 15343182
[TBL] [Abstract][Full Text] [Related]
3. Early treatment with ursodeoxycholic acid for cholestasis in children on parenteral nutrition because of primary intestinal failure.
De Marco G; Sordino D; Bruzzese E; Di Caro S; Mambretti D; Tramontano A; Colombo C; Simoni P; Guarino A
Aliment Pharmacol Ther; 2006 Jul; 24(2):387-94. PubMed ID: 16842466
[TBL] [Abstract][Full Text] [Related]
4. Ursodeoxycholic acid treatment in preterm infants: a pilot study for the prevention of cholestasis associated with total parenteral nutrition.
Arslanoglu S; Moro GE; Tauschel HD; Boehm G
J Pediatr Gastroenterol Nutr; 2008 Feb; 46(2):228-31. PubMed ID: 18223390
[TBL] [Abstract][Full Text] [Related]
5. The biochemical and histopathological effects of ursodeoxycholic acid and metronidazole on total parenteral nutrition-associated hepatic dysfunction: an experimental study.
Günsar C; Melek M; Karaca I; Sencan A; Mir E; Ortaç R; Canan O
Hepatogastroenterology; 2002; 49(44):497-500. PubMed ID: 11995481
[TBL] [Abstract][Full Text] [Related]
6. Ursodeoxycholic acid for treatment of cholestasis in children on long-term total parenteral nutrition: a pilot study.
Spagnuolo MI; Iorio R; Vegnente A; Guarino A
Gastroenterology; 1996 Sep; 111(3):716-9. PubMed ID: 8780577
[TBL] [Abstract][Full Text] [Related]
7. Total parenteral nutrition-associated intrahepatic cholestasis in infants: 25 years' experience.
Kubota A; Yonekura T; Hoki M; Oyanagi H; Kawahara H; Yagi M; Imura K; Iiboshi Y; Wasa K; Kamata S; Okada A
J Pediatr Surg; 2000 Jul; 35(7):1049-51. PubMed ID: 10917294
[TBL] [Abstract][Full Text] [Related]
8. Ursodeoxycholic acid therapy in children with cholestatic liver disease.
Dinler G; Koçak N; Yüce A; Gürakan F; Ozen H
Turk J Pediatr; 1999; 41(1):91-8. PubMed ID: 10770681
[TBL] [Abstract][Full Text] [Related]
9. [Cholestasis associated with prolonged parenteral nutrition in neonates: the role of urso-deoxycholic acid].
Garzón L; Ledo A; Cubells E; Sáenz P; Vento M
An Pediatr (Barc); 2009 Jun; 70(6):547-52. PubMed ID: 19443280
[TBL] [Abstract][Full Text] [Related]
10. Intrauterine growth restriction impacts tolerance to total parenteral nutrition in extremely low birth weight infants.
Baserga MC; Sola A
J Perinatol; 2004 Aug; 24(8):476-81. PubMed ID: 15141267
[TBL] [Abstract][Full Text] [Related]
11. Ursodeoxycholic acid in the treatment of cholestasis and hyperbilirubinemia in pediatric intensive care unit patients.
George R; Stevens A; Berkenbosch JW; Turpin J; Tobias J
South Med J; 2002 Nov; 95(11):1276-9. PubMed ID: 12539993
[TBL] [Abstract][Full Text] [Related]
12. Enteral nutrition and total parenteral nutrition components in the course of total parenteral nutrition-associated cholestasis in neonatal necrotizing enterocolitis.
Veenstra M; Danielson L; Brownie E; Saba M; Natarajan G; Klein M
Surgery; 2014 Sep; 156(3):578-83. PubMed ID: 24962191
[TBL] [Abstract][Full Text] [Related]
13. Liver disease associated with ZZ alpha1-antitrypsin deficiency and ursodeoxycholic acid therapy in children.
Lykavieris P; Ducot B; Lachaux A; Dabadie A; Broué P; Sarles J; Bernard O; Jacquemin E
J Pediatr Gastroenterol Nutr; 2008 Nov; 47(5):623-9. PubMed ID: 18955864
[TBL] [Abstract][Full Text] [Related]
14. A controlled trial of erythromycin and UDCA in premature infants during parenteral nutrition in minimizing feeding intolerance and liver function abnormalities.
Gokmen T; Oguz SS; Bozdag S; Erdeve O; Uras N; Dilmen U
J Perinatol; 2012 Feb; 32(2):123-8. PubMed ID: 21566568
[TBL] [Abstract][Full Text] [Related]
15. Ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy. A 12-year experience.
Zapata R; Sandoval L; Palma J; Hernández I; Ribalta J; Reyes H; Sedano M; Tohá D; Silva JJ
Liver Int; 2005 Jun; 25(3):548-54. PubMed ID: 15910492
[TBL] [Abstract][Full Text] [Related]
16. Treatment of obstructive jaundice in erythroblastosis fetalis with ursodeoxycholic acid (UDCA): a case report.
Perez EM; Cooper TR; Moise AA; Ferry GD; Weisman LE
J Perinatol; 1998; 18(4):317-9. PubMed ID: 9730206
[TBL] [Abstract][Full Text] [Related]
17. Aminosyn PF or trophamine: which provides more protection from cholestasis associated with total parenteral nutrition?
Forchielli ML; Gura KM; Sandler R; Lo C
J Pediatr Gastroenterol Nutr; 1995 Nov; 21(4):374-82. PubMed ID: 8583287
[TBL] [Abstract][Full Text] [Related]
18. Preventive effect of ursodeoxycholic acid on parenteral nutrition-associated liver disease in infants.
Simić D; Milojević I; Bogićević D; Milenović M; Radlović V; Drasković B; Benka AU; Sindjić S; Maksimović R
Srp Arh Celok Lek; 2014; 142(3-4):184-8. PubMed ID: 24839773
[TBL] [Abstract][Full Text] [Related]
19. Ursodeoxycholic acid treatment in isolated chronic graft-vs.-host disease of the liver.
Arat M; Idilman R; Soydan EA; Soykan I; Erden E; Karayalçin S; Akan H
Clin Transplant; 2005 Dec; 19(6):798-803. PubMed ID: 16313328
[TBL] [Abstract][Full Text] [Related]
20. Failure of cholecystokinin-octapeptide to prevent TPN-associated gallstone disease.
Tsai S; Strouse PJ; Drongowski RA; Islam S; Teitelbaum DH
J Pediatr Surg; 2005 Jan; 40(1):263-7. PubMed ID: 15868595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
